Nasrulla Abutaleb1. Show Affiliations » 1. KFSH-D, Dammam, Saudi Arabia. abutaleb_k@hotmail.com
Abstract
Mesh： See more » Angiotensin II Type 1 Receptor Blockers/adverse effectsAngiotensin II Type 1 Receptor Blockers/therapeutic useAngiotensin-Converting Enzyme Inhibitors/adverse effectsAngiotensin-Converting Enzyme Inhibitors/therapeutic useBenzimidazoles/adverse effectsBenzimidazoles/therapeutic useBenzoates/adverse effectsBenzoates/therapeutic useBlood Pressure/physiologyChronic DiseaseDose-Response Relationship, DrugDrug Therapy, CombinationGlomerular Filtration Rate/physiologyHumansKidney Diseases/drug therapyKidney Diseases/physiopathologyRamipril/adverse effectsRamipril/therapeutic useTelmisartanTreatment Outcome
Substances： See more » Angiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme InhibitorsBenzimidazolesBenzoatesRamiprilTelmisartan
Year: 2009 PMID： 19934088 DOI： 10.1093/ndt/gfp633
Source DB: PubMed Journal: Nephrol Dial Transplant ISSN： 0931-0509 Impact factor: 5.992